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218 Abstract
19 Cocoa is rich in polyphenols and methylxanthines and it has been reported that its consumption, 
20 among other properties, has beneficial effects on metabolism. This study aimed to investigate the 
21 role of theobromine in cocoa’s metabolic properties in healthy rats. In addition to morphometric 
22 measurements, biochemical markers of lipids and glucose metabolism and gene expression of 
23 molecules related to immune cells in adipose and hepatic tissues were assessed after 7 or 18 days of 
24 diet. Additionally, a metabolomic analysis was carried out at day 7. This study revealed the 
25 presence of six discriminant metabolites in plasma due to the diets. Moreover, the results showed 
26 that theobromine is the main responsible factor for cocoa’s effects on body weight gain as well as 
27 on lipid and glucose metabolism. The effects on body weight and lipids appeared as early as after 7 
28 days of diet, whereas those affecting glucose metabolism required a longer intervention. 
29 Keywords: body weight; cholesterol; HDL-cholesterol; fat; ghrelin; glucose; methylxanthine 
30
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332 INTRODUCTION
33 Cocoa is a product obtained from the seeds of the Theobroma cacao L. tree, which contains fiber, 
34 proteins, carbohydrates, lipids, minerals, vitamins, polyphenols and methylxanthines1,2. Within 
35 polyphenols, cocoa mainly contains flavonoids, the most important ones being the flavan-3-ols, 
36 such as epicatechin, catechin and procyanidins. Otherwise, theobromine (3,7-dimethylxanthine) is 
37 the methylxanthine found in the highest concentration in cocoa3.
38 In recent years, cocoa has increasingly attracted attention because of its potential health effects4. 
39 Cocoa’s anti-inflammatory, antioxidant, anti-allergy and anti-obesity properties have been reported; 
40 its intake also influences mood, intestinal microbiota, the cardiovascular system and, interestingly, 
41 the metabolic profile4–9. Within the role of cocoa in metabolic properties, it has been shown that 
42 cocoa consumption has a beneficial effect on obesity as well as in the improvement of glucose, 
43 lipids and insulin levels8,10,11. Preclinical studies evidenced that the consumption of a 10% cocoa-
44 enriched diet for 9 weeks in diabetic Zucker rats lowered glucose and insulin levels, and improved 
45 glucose tolerance and insulin resistance12. Similarly, the administration of 8% cocoa powder to 
46 mice with high-fat-diet-induced obesity reduced body weight (BW) gain, and insulin resistance11. 
47 Likewise, mice fed with high-fat-diet treated with a cocoa polyphenol concentrate decreased 
48 adipose tissue mass and plasma triglycerides (TG), and consequently the BW gain, without 
49 modifications in plasma glucose and cholesterol levels13. Otherwise, obese diabetic rats fed a cocoa 
50 extract enriched with polyphenols and methylxanthines for 4 weeks showed reduced plasma total 
51 cholesterol, TG and low-density lipoprotein cholesterol14. Apart from the cocoa metabolic effects in 
52 rodents, interventional studies in humans have reinforced the role of cocoa in body metabolism. 
53 Thus, overweight/obese premenopausal women consuming a sugar-free natural cocoa beverage and 
54 dark chocolate twice a day for 18 weeks, decreased plasma glucose and insulin concentrations15, 
55 and a similar population consuming dark chocolate for 7 days had higher HDL cholesterol (HDL-c) 
56 and reduced the abdomen circumference16. Moreover, Martínez-López et al. reported that the 
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457 consumption of a soluble cocoa product increased serum HDL-c whereas anthropometric 
58 parameters were unaffected17. 
59 In our previous studies developed in rats, we detected that the administration of a diet containing 
60 10% cocoa was associated with a lower BW gain18–21. More recently, we have shown that the 
61 attenuating effect on antibody production and the lowering of BW gain in rats fed cocoa were 
62 similar to that observed in rats receiving theobromine alone22. These results prompted us to consider 
63 whether theobromine may also contribute to the effects of cocoa intake on glucose and lipid 
64 metabolism. For this reason, the present study aimed to establish the role of theobromine in 
65 metabolic cocoa’s properties. Apart from comparing the metabolic profile induced by cocoa and 
66 theobromine diets, rat physical activity was measured and an untargeted metabolomics study was 
67 carried out. 
68 MATERIALS AND METHODS
69 Reagents and biological material
70 Cocoa powder was obtained from Idilia Foods S.L. (formerly Nutrexpa S.L., Barcelona, Spain), 
71 theobromine was purchased from Sigma-Aldrich (Madrid, Spain) and AIN-93M diet and basal mix 
72 by Harlan Teklad (Madison, USA). Ketamine was from Merial Laboratories S.A. (Barcelona, 
73 Spain) and xylazine from Bayer A.G. (Leverkusen, Germany). Polymerase Chain Reaction (PCR) 
74 TaqMan® primers were provided by Applied Biosystems (Weiterstadt, Germany). Rats were 
75 obtained from Janvier Labs (Saint-Berthevin Cedex, France).
76
77 Experimental design
78 Forty 3-wk-old Lewis rats were maintained at the animal facilities of the Faculty of Pharmacy and 
79 Food Science (University of Barcelona) and kept under controlled conditions of temperature and 
80 humidity in a 12h:12h light:dark cycle. This study was conducted in accordance with institutional 
81 guidelines for the Care and Use of Laboratory Animals and was approved by the Ethical Committee 
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582 for Animal Experimentation of the University of Barcelona and the Catalonia Government 
83 (CEEA/UB ref. 380/13 and DAAM 5988, respectively). The rats were distributed according to diet 
84 into three groups (n=12−14 each one): reference group (RF group) fed standard diet (AIN-93M), 
85 cocoa group (CC group) fed a diet containing 10% (w/w) cocoa powder (with a content of 2.5% 
86 theobromine), and the theobromine group (TB group) fed a 0.25% theobromine diet, which had the 
87 same amount of theobromine as that provided in the CC group. Diets containing cocoa and 
88 theobromine were prepared in our own laboratory, mixing ingredients (Teklad diets, Envigo, 
89 Indianapolis, USA) in the required quantities to provide the same amount of energy, micronutrients 
90 and macronutrients as the standard diet (Supporting Table 1). After mixing, food pellets were made 
91 and dried. The animals had access to food and water ad libitum throughout the study. 
92 Rats were housed in cages (2−3 rats in each cage). During some periods (days 5 to 7 and days 9 to 
93 14), animals were individually housed in order to establish their motor activity. The nutritional 
94 intervention lasted for 7 or 18 days (Figure 1). After these periods, rats were deprived of food for 
95 18 h and were then euthanized for sample collection. 
96 Data and sample collection
97 Food and water intake (FI and WI, respectively) were monitored throughout the study. BW, body 
98 length (BL), and rectal body temperature were determined just before euthanasia. Body mass index 
99 (BMI), Lee index and food efficiency were also calculated. On days 8 and 19, inguinal and 
100 retroperitoneal adipose tissues, heart, liver, right kidney, small intestine and large intestine (colon 
101 and caecum) were collected and weighted. Moreover, plasma was obtained and stored at -80 ºC 
102 until processing. At day 8, inguinal adipose tissue and liver were kept at -80 ºC until mRNA 
103 quantification and/or biochemical variables determination. 
104 Biochemical determinations in plasma and liver
105 Plasma total cholesterol, HDL-c, TG, and glucose concentrations were determined by specific 
106 colorimetric kits (Química Clínica Aplicada S.A., Spain), following the manufacturer’s instructions 
107 adapted to a microplate. Absorbance was measured at 505 nm (microplate Tecan photometer, Tecan 
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6108 Group Ltd, Männedorf, Switzerland). LDL cholesterol (LDL-c) concentration was estimated by 
109 means of the Friedewald formula (LDL-c = total cholesterol – (HDL-c - TG/5)). In order to measure 
110 hepatic TG, frozen liver tissue samples were homogenized with a Polytron® (Kinematica, Lucerne, 
111 Switzerland) in isopropanol (1 mL/50 mg liver), kept for 1 h at 4 ºC and then centrifuged (1313 g, 4 
112 ºC, 5 min). Supernatants were used for TG determination. 
113 Metabolic hormones determination
114 Plasma ghrelin, glucagon, glucagon-like peptide (GLP-1) and leptin were evaluated after fasting in 
115 19-day samples, with the Bio-Plex Pro™ Diabetes Assay (Bio-Rad Laboratories, Madrid, Spain). 
116 The lower and upper limits of quantification were: 159.58−155595.25 pg/mL (ghrelin), 
117 23.43−1316.37 pg/mL (glucagon), 8.44−1999.39 pg/mL (GLP-1) and 123.73−130750.77 pg/mL 
118 (leptin). Plasma insulin was measured using an ultra-sensitive ELISA kit (Ultra Sensitive Rat 
119 Insulin ELISA kit) from Crystal Chem (Downers Grove, IL, USA) according to the manufacturer’s 
120 instructions. 
121 Fecal fat content and pH determinations
122 Feces collected from the whole of day 7 were humidified and submitted to near infrared 
123 spectroscopy to determine the fat content by means of an InfraAlyzer 500 (Bran+Luebbe, 
124 Norderstedt, Germany). Furthermore, fecal pH determination was performed in feces from days 7 
125 and 18 using a surface pH electrode (Crison Instruments, SA, Barcelona, Spain).
126 Gene expression quantification 
127 In liver and adipose tissue samples, we determined the gene expression of molecules expressed in 
128 particular immune cells, such as CD11b (monocytes, neutrophils, natural killer cells, granulocytes 
129 and macrophages), CD11c (monocytes, granulocytes, some B cells, dendritic cells and 
130 macrophages), CD68 (monocytes and macrophages), CD4 (predominant on T helper cells, but also 
131 in macrophages, monocytes and dendritic cells), CD8α (predominant on cytotoxic T cells and in 
132 natural killer cells and dendritic cells) and Foxp3 (regulatory T cells). In addition, we quantified the 
133 gene expression of pro-inflammatory cytokines, such as interleukine (IL)-1β, TNFα, IL-6, MCP-1 
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7134 and IFN, anti-inflammatory cytokines, such as IL-4 and IL-10, and the transcription factors NF-κB 
135 (involved in inflammation) and PPAR- (present in adipose tissue and macrophages and involved in 
136 inflammation regulation). For this, liver and adipose tissue samples were homogenized in a lysing 
137 matrix tube (MP Biomedicals, Illkirch, France) by a FastPrep-24 equipment (MP Biomedicals, 30 s, 
138 at 6.5 m/s). Total RNA was extracted using the RNeasy® mini kit (Qiagen, Madrid, Spain) 
139 following the manufacturer’s directions. The NanoPhotometer (BioNova Scientific, CA, USA) was 
140 used to determine RNA concentration. A thermal cycler PTC-100 Programmable Thermal 
141 Controller with TaqMan® Reverse Transcription Reagents (Applied Biosystems, AB, Weiterstadt, 
142 Germany) was applied to obtain cDNA. Subsequently, a PCR quantitative assay was carried out 
143 (ABI Prism 7900 HT, AB) using the following specific PCR TaqMan® primers: CD11b 
144 (Rn00709342_m1, Inventoried (I)), CD11c (Rn01511082_m1, I), CD68 (Rn01495634_m1, I), CD4 
145 (Rn00562286_m1, I), CD8α (Rn00580577_m1, I), FoxP3 (Rn01525092_m1, I), IL-1β 
146 (Rn00580432_m1), IL-10 (Rn00563409_m1, I), IL-6 (Rn01410330_m1, I), TNFα 
147 (Rn99999017_m1, I), NF-κB (Rn01399572_m1, I), IFN (Rn00694078_m1, I) PPAR 
148 (Rn00440945_m1, I), MCP-1 (Rn00580555_m1, I). The relative amount of target mRNA was 
149 normalized using β-actin (Rn00667869_m1, I) or HPRT1 (Rn01527840_m1, I) as housekeeping 
150 genes and the 2-ΔΔCt method, as previously described23. The gene expression obtained was 
151 calculated giving the 1 value to the mean results from the RF group. 
152 Metabolomic analyses
153 The untargeted metabolomics analyses were performed on plasma samples collected after 7 days of  
154 intervention with a high-performance liquid chromatography coupled to electrospray ionization and 
155 quadrupole time-of-flight mass spectrometry (HPLC-ESI-QToF-MS) as previously published24. 
156 Detailed description is given as Supporting Information (Supporting Table 2). 
157 Motor activity measurement
158 Spontaneous motor activity of each animal was continuously recorded on days 5 to 7 and 9 to 14 by 
159 means of activity meters placed outside the cage that used two perpendicular crossed infrared beams 
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8160 situated 6 cm above the floor of the cage. Each beam interruption represented an activity count that 
161 was registered and stored in 15-min data bins for further analysis. Total daily activity was 
162 calculated as well as the nocturnal and diurnal activity separately. Results are expressed as the mean 
163 values (counts every 15 minutes).
164 Statistical analysis
165 Data were evaluated with the software package SPSS 22.0 (IBM Statistical Package for the Social 
166 Sciences, version 22.0, Chicago, IL, USA) by using the parametric test one-way ANOVA followed 
167 by Bonferroni’s post hoc test or the nonparametric tests Kruskal–Wallis and Mann–Whitney U in 
168 accordance with its homogeneity of variance (Levene test) and distribution (Shapiro-Wilk test).  
169 Significant differences were established when P≤0.05.
170 Significant mass features selected after multi- and univariate statistical analyses of the 
171 metabolomics dataset were identified by a multistep procedure as specified in Supporting 
172 Information. Untargeted metabolomics data were analyzed by multivariate statistical methods using 
173 SIMCA-P+ 13.0 software (Umetrics, Umea, Sweden). Particular statistical analysis for these data is 
174 expanded in the Supporting Information.
175 The metabolites identified by the untargeted metabolomics analysis were correlated with the results 
176 from BW gain, BMI, Lee index, FI, WI, inguinal, retroperitoneal, small and large intestine tissue 
177 weights, fecal fat, plasma total cholesterol, HDL-c and LDL-c concentrations and hepatic TG 
178 levels. For this, after a log-transformation of results, Spearman’s correlation analyses were 
179 performed. The Benjamini−Hochberg method was used to adjust p-values for multiple testing 
180 considering a 5% false discovery rate.
181 RESULTS
182 Morphometric variables 
183 Morphometric changes were already detected after 7 days of the experimental diets (Table 1). 
184 Specifically, the animals from the CC and TB groups had lower BW gain (P<0.001). Moreover, the 
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9185 rats fed CC and TB diets for 18 days presented lower body length than those of the RF group 
186 (P<0.001). Decreased BMI was found in the CC and TB groups (P<0.05) on days 8 and 19 and, 
187 additionally, on day 8 the Lee index in both interventional groups was lower than in the RF animals 
188 (P<0.05). In any case, no differences were detected between CC and TB groups, the changes being 
189 almost identical between them. 
190 In spite of the lower values in morphometric changes, mean FI did not decrease in the CC or TB 
191 groups, but mean WI increased in both interventional groups compared to the RF one (P<0.001) 
192 (Table 1). With regard to food efficiency, the CC and TB groups showed lower values than the RF 
193 animals, which was already evidenced after one single week of diet (P<0.05) (Table 1). 
194 Body temperature and spontaneous physical activity 
195 Rectal temperature was measured at days 7 and 18. There were no changes in body temperature 
196 between the considered groups at any of the studied time points (Table 1). Moreover, motor activity 
197 was individually measured between days 5 to 7 and days 9 to 14. In the first period, cocoa diet 
198 decreased diurnal motor activity compared to the RF group (Figure 2a−b) without statistically 
199 significant changes when considering the whole day. In the second period, higher activity was 
200 observed in animals fed cocoa diet than in those from the RF group, both in diurnal and nocturnal 
201 determinations. The activity in the TB group did not achieve a significant modification compared to 
202 RF animals (Figure 2c−d).
203 Relative organ and tissue weights
204 After euthanasia on days 8 or 19, some organs and adipose tissues were collected and weighed 
205 (Table 1). Animals from the CC and TB groups showed lower relative retroperitoneal fat weight at 
206 both time points (P<0.05), although the relative inguinal fat weight was lower only in the TB group 
207 after 18 days of diet. The rats fed cocoa for 18 days had higher relative heart weight (P<0.05). In 
208 the two studied time points no changes in the relative kidney weight were observed. However, the 
209 CC and TB groups had lower relative liver weight than the RF group (P<0.01), the TB value being 
210 even lower than that of the CC group after 18 days of diet (P<0.05). On the other hand, the relative 
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211 small and large intestinal weights were higher after 7 and 18 days of the two experimental diets in 
212 comparison to the RF group (P<0.05) (Table 1). 
213 Fecal fat and pH values
214 Fecal fat content, determined after 7 days of diet, was lower in cocoa- and theobromine-fed animals 
215 in comparison to the RF group (P<0.01), and even the rats from the CC group showed less fecal fat 
216 levels than the TB group (P<0.05) (Figure 3). Otherwise, cocoa diet lowered fecal pH detected at 
217 day 18 in comparison to the RF and TB groups (P<0.05) (Figure 3).
218 Cholesterol and triglyceride concentrations 
219 After 7 days of diet, the total plasma cholesterol concentrations in both CC and TB groups were 
220 about 15% lower than those detected in the RF group (P<0.05) (Table 2). Nevertheless, no 
221 differences were detected later. Similar results were observed in LDL-c content. Interestingly, 
222 HDL-c values increased by 24−41% in the CC and TB groups at both studied time points (P<0.05) 
223 (Table 2). Moreover, plasma TG concentrations from the TB group were significantly lower after 
224 18 days of diet (P<0.01) (Table 2) while hepatic TG concentrations decreased after both cocoa and 
225 theobromine diets, this already observable just after one week of diet (P<0.001) (Table 2).
226 Liver and adipose tissue gene expression 
227 The influence of diets containing cocoa or theobromine on the gene expression of some immune 
228 molecules in hepatic and adipose tissues was quantified after one week of diet (Figures 4 and 5). 
229 With regard to the liver (Figure 4), cocoa-enriched diet reduced the gene expression of CD11c and 
230 CD4 without inducing significant changes in CD11b, CD68, Foxp3, TNF-α, NF- and PPAR-. 
231 Moreover, both CC and TB groups showed lower mRNA levels of CD8α, IL-10 and IL-1β with 
232 respect to the RF group. The TB group had higher TNF-α and NF-B hepatic gene expressions than 
233 the RF and CC groups (P<0.05). In this tissue, the mRNA levels of IL-4, IL-6, MCP-1 were 
234 undetectable in any of the considered groups. 
235 With regard to adipose tissue (Figure 5), the gene expression of CD11b, CD11c, Foxp3, IFN-γ, 
236 TNF-α, IL-4, and IL-6 was undetectable. Both nutritional interventions induced an upregulation of 
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237 the CD68 and MCP-1 gene expression and a downregulation of the CD4 expression with respect to 
238 the RF group (P<0.05). Moreover, animals fed cocoa had higher gene expression of IL-10 and 
239 IL-1β whereas the TB group showed lower gene expression of CD8α in comparison to the RF 
240 animals. No changes in NF-B and PPAR- expressions were found in the CC and TB groups. 
241 Glucose metabolism
242 After 7 days of diet, the plasma glucose concentrations in fasting conditions were similar within 
243 groups, however, after 18 days, the CC and TB groups had higher plasma glucose concentrations 
244 than the RF group (Table 2). At this later time point, plasma ghrelin, glucagon, GLP-1, leptin and 
245 insulin concentrations were determined (Figure 6). The rats from CC and TB groups showed higher 
246 ghrelin concentrations and lower glucagon levels than the RF group (P<0.01 and P<0.05, 
247 respectively). In fasting conditions, GLP-1 and leptin levels were below the limit of detection in the 
248 three experimental groups. There was no difference in plasma insulin levels among the studied 
249 groups, although a tendency to decrease (P=0.092) was observed after both experimental diets.
250 Metabolomic analyses
251 The metabolomic analyses are detailed in the supporting information (Supporting Information 
252 Figure S1 and Tables S3 and S4). As mentioned in the Material and Methods section, only features 
253 showing high correlation coefficients (|p(corr)| > 0.75) in all models developed during the leave-
254 one-out procedure were included in the list of discriminating metabolites explaining the differences 
255 between groups, which were then submitted to the metabolite identification procedure. A total of 
256 185 features fulfilled this criteria, 135 features from the ESI(+) data set and 50 features from the 
257 ESI(–) data set. The scores plot of the three-group PLS-DA models with non-OSC filtered data 
258 using the selected features revealed higher differences (displayed through PC1) between the REF 
259 group and the other two groups, followed by differences between the animals supplemented with 
260 cocoa and those supplemented with theobromine (PC2), indicating that each diet induced a different 
261 metabolomic pattern (Figure 7). Among the features selected as significant, eight of them were 
262 assigned to the six compounds that were identified as discriminant metabolites. They were related 
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263 to at least one of the study groups: theobromine, pantothenic acid, glycocholic acid, citrulline, 5-(2’-
264 carboxyethyl)-4,6-dihydroxypicolinate (CEDHP), and 5-hydroxyindoleacetic acid (HIAA) (Figure 
265 8). Mass features of these compounds are listed in the Supporting Information Table S5. 
266 Theobromine was an exogenous metabolite only found in the CC and TB groups and, as expected, 
267 there were no differences between the two experimental diets. As endogenous metabolites, the CC 
268 and TB groups showed higher concentrations of pantothenic acid and glycocholic acid than the RF 
269 group (p<0.05). Moreover, the TB group exhibited higher levels of citrulline compared with the RF 
270 group, and higher levels of CEDHP in comparison to both the RF and CC groups (P<0.05). Finally, 
271 the intake of both cocoa- and theobromine-enriched diets induced lower levels of HIAA than those 
272 in the RF group. 
273 Correlations between morphometric and biochemical data, and the discriminant metabolites
274 In order to determine the relationship between the discriminant metabolites and morphometric and 
275 biochemical significant results obtained at the same time point, correlations between both data were 
276 carried out (Figure 9). Theobromine plasma concentration correlated negatively with BMI, 
277 retroperitoneal fat weight and hepatic TG, whereas it correlated positively with WI, small and large 
278 intestine weights as well as with plasma HDL-c levels. Almost similarly, the plasma concentrations 
279 of pantothenic acid negatively correlated with BW gain, BMI, food efficiency and hepatic TG while 
280 it correlated directly with higher WI and small intestine weight.
281 Moreover, the more plasma concentration of glycocholic acid detected, the lower the fecal fat 
282 observed. Likewise, higher citrulline concentrations correlated with higher levels of HDL-c. The 
283 amount of the metabolite CEDHP correlated positively with the large intestinal relative weight and 
284 negatively with plasma TG. Regarding the metabolite HIAA, found in lower concentrations in the 
285 CC and TB groups, it positively correlated with lower BW gain, BMI, fecal fat content, total 
286 cholesterol, LDL-c and plasma TG. Otherwise, HIAA correlated negatively with WI and small and 
287 large intestinal relative weights.  
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288 Regarding the Lee index, FI and inguinal fat weight, no significant correlation was detected with 
289 any of the studied metabolites. 
290 DISCUSSION
291 Previous studies have reported the effect of cocoa on metabolism8,11–13,25,26. However, the exact 
292 compound responsible for such effect and the length needed to achieve such benefits still remain 
293 unknown and are a topic of debate. Although polyphenols and methylxanthines are recognized 
294 bioactive compounds in cocoa3, a vast number of studies have associated the cocoa role in 
295 metabolism only with its polyphenol content. In the current study, we evidence the importance of 
296 theobromine in the metabolic properties of cocoa as well as its rapid effects.
297 Rats fed with 10% cocoa that consumed a similar or even higher amount of food than the RF group, 
298 underwent a lower body weight gain as early as after 7 days of diet, which was accompanied by 
299 lower BMI and Lee’s index. Importantly, theobromine on its own produced similar actions. Cocoa 
300 effects on body weight increase have already been reported both in animal models and humans11–
301 13,15,27 and it has been postulated that cocoa is a weight loss accelerator28. Our results concerning 
302 body temperature and motor activity demonstrated that, at least after the first week of diet, there 
303 was no increase in the metabolic rate. The metabolomic analyses carried out after 7 days of diet 
304 showed that BMI inversely correlated with the plasma concentrations of theobromine, which is in 
305 line with a previous study showing a negative association of BMI with the amount of theobromine 
306 in urine of rats fed cocoa for 3 weeks29. On the other hand, we found a higher water intake in 
307 animals fed cocoa or theobromine, data that correlated directly with the plasma concentrations of 
308 theobromine. This higher water intake could be a consequence of the theobromine’s diuretic 
309 actions30 in order to compensate the high volume of excreted urine. Overall, these results allow us 
310 to conclude that cocoa theobromine content is an important cocoa metabolite involved in the body 
311 weight homeostasis. 
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312 In line with a reduced body weight gain and BMI, rats fed cocoa or theobromine diets had a lower 
313 amount of retroperitoneal fat after 7 and 18 days of diet. These results agree with those reported in 
314 high-fat-fed obese mice fed 8% cocoa powder11 and with a study carried out in European 
315 adolescents reporting that higher chocolate consumption was related with lower fatness31. After 7 
316 days of diet, as observed by correlations after metabolomic analyses, the higher the plasma 
317 theobromine concentration, the lower the amount of retroperitoneal fat found. Thus, it can be 
318 suggested that these cocoa effects on adipose tissue could be due to its theobromine content. 
319 However, the proportion of inguinal fat in the theobromine group at day 19 was lower than that in 
320 the cocoa group, suggesting that other cocoa compounds (polyphenols and/or fiber) could attenuate 
321 this particular effect.  On the other hand, adipose tissue is an immune organ that links metabolism 
322 and immunity32. In this sense, it has been described that cocoa intake decreased macrophage 
323 infiltration in adipose tissue in obese mice11. However, in this tissue, we have detected a higher 
324 gene expression of CD68 and MCP-1 (molecules present in macrophages and involved in their 
325 recruitment, respectively) after cocoa and theobromine intake, and higher IL-1 gene expression in 
326 cocoa-fed rats. These discrepancies could be due to the status of the animals − healthy status in the 
327 current study and obese status in the first described case11 − which had already shown an increased 
328 macrophage infiltration before cocoa intake. Nevertheless, although some macrophage-related 
329 molecules increased, other transcriptional factors related to macrophage or immune activation, such 
330 as NF-B and PPAR-, were not modified by cocoa or theobromine diets, and, interestingly, the 
331 cocoa diet increased the adipocyte gene expression of the anti-inflammatory cytokine IL-10. 
332 Similarly, the gene expression of CD4 was down-regulated by cocoa and theobromine intake, and 
333 that of CD8 only by the theobromine diet. Both CD4 and CD8 are mainly related to lymphocytes 
334 and their decrease suggests that there was lower lymphocyte infiltration into the fat. In short, results 
335 of adipocyte gene expression suggest that cocoa, partially due to its theobromine content, may be 
336 involved in avoiding the low-grade inflammatory status observed in obesity32. Nevertheless, 
337 because the effect in fat gene expression of both cocoa- and theobromine-enriched diets differed in 
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338 some molecules, the role of other cocoa bioactive compounds such as polyphenols or fiber cannot 
339 be discarded. 
340 Fecal samples obtained after 7 days of cocoa or theobromine diet also provided significant results 
341 regarding fat content. We found that the fecal fat content in animals fed theobromine and cocoa 
342 decreased. These results do not agree with those reported in obese mice fed a cocoa diet11 or in 
343 obese animals fed with other phytotherapeutic diets33. This disagreement could again be due to the 
344 different status of the animals or to the different technique used. Nevertheless, we observed that the 
345 two experimental diets exerted a similar effect, although it was more obvious in the cocoa group, 
346 suggesting the role of other compounds present in the whole cocoa diet in fat excretion.
347 A relevant outcome observed in the current study was the influence of cocoa and theobromine on 
348 plasma lipids such as cholesterol. Although we found that cocoa diet decreased plasma 
349 concentrations of total cholesterol and LDL-c, after 7 days of diet, this effect was not longer 
350 detected. In fact, it has been reported that in rats fed a high-fat diet with 12.5% cocoa for 21 days34 
351 no decrease was seen in either plasma cholesterol or LDL-c levels, which also agree with studies 
352 carried out in humans35,36. Nevertheless, both the cocoa diet and the diet containing only 
353 theobromine increased plasma HDL-c levels. Similar effects have been reported in humans after a 
354 nutritional intervention with cocoa35,36 and with rats fed a high-fat diet plus cocoa34. The increase in 
355 HDL-c concentration correlated with the plasma levels of theobromine. In partial agreement with 
356 this, a recent study in humans taking 500 mg/day theobromine for 4 weeks37 demonstrates that 
357 theobromine consumption tended to increase fasting plasma HDL-c concentrations. Overall, the 
358 current results indicate that in the reported beneficial effects of cocoa intake on plasma lipids, 
359 theobromine from cocoa content plays a relevant role. Although the results obtained from the cocoa 
360 diet agree with a previous study showing a downregulation of colonic Adipoq gene expression, 
361 which is involved in lipid metabolism38, further studies must be carried out to establish the effects 
362 of both cocoa and theobromine on key enzymes related to lipid metabolism.
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363 On the other hand, cocoa diet and its methylxanthine alone influence the hepatic tissue. After one 
364 week of both diets there was a reduction in hepatic triglycerides and changes in the gene expression 
365 of several molecules. These results on hepatic triglycerides are in line with those reported in adult 
366 mice fed with a high-fat diet plus 8% cocoa11, although the effects obtained here were more 
367 obvious, which could be due to the use of younger animals fed a standard diet, the higher cocoa 
368 proportion and/or the cocoa’s composition. Anyway, despite the fact that the effect of cocoa in the 
369 suppression of hepatic fatty acid synthesis and transport systems in mesenteric white adipose tissue 
370 has been reported34, the influence of cocoa on hepatic triglycerides deserves a more in-depth study. 
371 We also studied the hepatic gene expression of molecules involved in promoting or inhibiting 
372 inflammation. Although both diets decreased the gene expression of the pro-inflammatory cytokine 
373 IL-1β and cocoa intake down-regulated CD11c expression, there was a decrease in the expression 
374 of the anti-inflammatory IL-10 and theobromine intake increased the gene expression of TNF- and 
375 NF-B, promoting inflammation. On the other hand, CD4 and CD8 molecule gene expressions 
376 were down-regulated by cocoa and/or theobromine, suggesting lower lymphocyte presence in the 
377 liver. Overall, the results of the hepatic genes studied do not clarify whether immune mechanisms 
378 were involved in the effects of cocoa on the liver. Moreover, the intake of cocoa and theobromine 
379 did not show identical effects on the molecules considered, indicating that other bioactive 
380 compounds included in the whole cocoa diet can enhance or attenuate that of theobromine alone.
381 As previous studies demonstrated the influence of a cocoa diet on glucose metabolism12, we also 
382 tested plasma glucose concentrations, which did not vary after 7 days of diet but increased in the 
383 18-day samples in a similar way in both cocoa- and theobromine-fed animals. Therefore, we 
384 determined insulin concentrations, as well as hormones associated with glucose metabolism at this 
385 time point. The current study revealed that cocoa and theobromine on its own increased ghrelin 
386 levels and decreased glucagon concentration, as already reported in rats fed 10% cocoa29. Ghrelin, 
387 also known as the hunger hormone, is a multifaceted hormone secreted by the stomach, which is 
388 influenced by the BMI, glucose and insulin levels, among other factors39. Ghrelin is involved in the 
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389 inhibition of insulin secretion and contributes to glucose homeostasis, apart from regulating energy 
390 homeostasis40. Otherwise, glucagon is a hormone produced in the α cells of the pancreatic islets 
391 stimulated by low levels of glucose41. From our results obtained in fasting samples after 18 days of 
392 cocoa or theobromine diets, we can suggest that the higher ghrelin secretion might be due to 
393 stimulation from the lower BMI and could increase plasma glucose concentration, whereas it 
394 decreased glucagon levels and tended to decrease plasma insulin. The discrepancy between the 
395 current results and previous studies that show the antidiabetic effects of a cocoa diet could be due to 
396 the age of the rats at the beginning of the nutritional intervention as well as the use of healthy rather 
397 than diabetic animals. In fact, a study in humans taking dark chocolate found decreased plasma 
398 glucose concentrations when BMI25 kg/m2 but no changes when BMI<25 kg/m2 42. Although 
399 further studies are required to check the importance of age and the existence of diabetes/overweight 
400 in the cocoa/theobromine effects, our findings suggest that theobromine plays an important role in 
401 the influence of cocoa on glucose metabolism. In this sense, it has been reported that cocoa intake 
402 produces a downregulation of colonic Adipoq gene expression involved in glucose metabolism as 
403 well as that of lipids, as has been mentioned above38. 
404 Finally, it is important to highlight the levels of endogenous discriminant metabolites found after 
405 cocoa and/or theobromine intake and their correlations with some outcomes obtained after 7 days of 
406 diet. Higher plasma pantothenic acid was correlated with lower body weight gain, BMI, food 
407 efficiency and hepatic triglycerides, and higher water intake and small intestine weight. The 
408 pantothenic acid (vitamin B5) is a precursor for the coenzyme A (CoA) and acyl carrier protein, 
409 involved in the metabolism of steroids, fatty acids and phosphatides43. CoA is found in the pathway 
410 of cholesterol synthesis, amino acid catabolism, and is a crucial substrate in the oxidation of fatty 
411 acids44. The higher levels of pantothenic acid in cocoa and theobromine groups might be associated 
412 with an enhanced fatty-acid metabolism that would partially explain the lower body weight gain and 
413 the decrease in hepatic triglycerides as well as plasma cholesterol levels. Also related to the lipid 
414 metabolism, we found a negative correlation between the elevated glycocholic acid levels in cocoa 
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415 and theobromine groups and their reduced fecal fat content. As glycocholic acid is an indirect 
416 cholesterol-derived bile acid45, it can be suggested that a high amount of glycocholic in plasma 
417 could promote lipid metabolism. 
418 On the other hand, plasma citrulline concentrations were directly associated with those of HDL-c. 
419 Citrulline is a nonessential amino acid, precursor of arginine. In particular, from arginine and 
420 different cofactors NO-synthase produced NO with release of citrulline46. Although with the current 
421 results we cannot evidence the exact pathway affected by the citrulline increase, it has been 
422 reported, in agreement with the current results, that the supplementation of L-citrulline is associated 
423 with increased HDL-c levels47. 
424 The metabolite 5-(2’-carboxyethyl)-4,6-dihydroxypicolinate (CEDHP) was found in higher plasma 
425 concentrations in those animals receiving theobromine. This compound was derived from the 
426 tryptophan metabolism and comes from the kynurenine pathway. Our results are in line with the 
427 increased kynurenine production observed after black tea consumption48. In particular, CEDHP 
428 levels inversely correlated with plasma triglycerides, suggesting the involvement of this pathway, 
429 which is beneficial for the triglyceridemia status. Another metabolite indicating the implication of 
430 this pathway is the HIAA, which is the only one that was found in lower concentrations after cocoa 
431 and theobromine intake in comparison with the animals fed standard diet. HIAA was associated 
432 with a lot of changes found after cocoa or theobromine consumption, such as body weight increase, 
433 water intake, small and large intestine weights, fecal fat content and with plasma cholesterol and 
434 hepatic triglyceride levels. HIAA is involved in the tryptophan metabolism system, as it is a 
435 breakdown product of serotonin and considered as a marker for the endogenous serotonin 
436 turnover49. In fact, higher urinary HIAA excretion in rats has been reported after cocoa intake and 
437 has been related to cocoa tryptophan degradation by gut microbiota29. Therefore, it can be suggested 
438 that the changes in the microbiota induced by cocoa and theobromine would reduce the absorption 
439 of tryptophan that will be found in lower plasma concentrations after one week of diets containing 
440 both products. Interestingly, such lower absorption seems related to lower plasma cholesterol and 
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441 triglyceride concentrations. In this line, it has been shown that severe tryptophan restriction 
442 decreased body weight, body fat and lean mass in obese-prone rats50. 
443 In conclusion, from the results obtained in rats fed cocoa or only theobromine, we can conclude that 
444 this methylxanthine is the main factor responsible for cocoa’s effects on body weight gain as well as 
445 on the lipid and glucose metabolism. These effects on body weight and lipids appeared as early as 
446 after 7 days of diet, whereas those affecting glucose metabolism require a longer intervention. 
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447 Abbreviations 
448 AB, Applied Biosystems; BL, body length; BMI, body mass index; BW, body weight; CC, cocoa 
449 group; CEDHP, 5-(2’-carboxyethyl)-4,6-dihydroxypicolinate; CoA, coenzyme A; FI, food intake; 
450 GLP-1, glucagon-like peptide; HDL-c, high-density lipoprotein cholesterol; HIAA, 
451 hydroxyindoleacetic acid; HPLC-ESI-QToF-MS, high-performance liquid chromatography coupled 
452 to electrospray ionization and quadrupole time-of-flight mass spectrometry; IL, interleukin; LDL-c, 
453 low-density lipoprotein cholesterol; OSC-PLS-DA, partial least squares discriminant analysis with 
454 orthogonal signal correction; PCA, principal components analyses; PCR, polymerase chain 
455 reaction; QC, quality control; RF, reference group; TB; theobromine group; TG, triglycerides; WI, 
456 water intake
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606 Figure captions
607 Figure 1. Experimental design. The nutritional intervention lasted for 7 or 18 days. After these 
608 periods, rats were deprived of food for 18 h and were then euthanized. 
609 Figure 2. Mean motor activity from the three groups of study (white bars represent reference group 
610 (RF), grey bars represent cocoa group (CC), and striped bars represent theobromine group (TB)); 
611 during days 5 to 7 (a−b) and days 9 to 14 (c−d).  Values are expressed as mean ± standard error (n = 
612 6−7). Statistical difference: * p≤0.05 vs RF group by one-way ANOVA.
613 Figure 3. Fecal fat content and pH from the three groups of study (white bars represent reference 
614 group (RF), grey bars represent cocoa group (CC), and striped bars represent theobromine group 
615 (TB)). Values are expressed as mean ± standard error (n = 6−7). Statistical difference: * p≤0.05 vs 
616 RF group, and  p≤0.05 vs CC group by one-way ANOVA.
617 Figure 4. Liver gene expression. Liver gene expression from the three groups of study (white bars 
618 represent reference group (RF), grey bars represent cocoa group (CC); and striped bars represent 
619 theobromine group (TB)) in the 7 days-lasting experimental design. Values are expressed as mean ± 
620 standard error (n = 6−7). Statistical difference: * p≤0.05 vs RF group, and  p≤0.05 vs CC group by 
621 Mann-Whitney U test. 
622 Figure 5. Adipose tissue gene expression. Liver gene expression from the three groups of study 
623 (white bars represent reference group (RF); grey bars represent cocoa group (CC); and striped bars 
624 represent theobromine group (TB) in the 7-day experimental design. Values are expressed as mean 
625 ± standard error (n = 6−7). Statistical difference: * p≤0.05 vs RF group by Mann-Whitney U test.
626 Figure 6. Metabolic variables. Ghrelin, glucagon and insulin concentration from the three groups of 
627 study (white bars represent reference group (RF), grey bars represent cocoa group (CC), and striped 
628 bars represent theobromine group (TB)) in the 19-day experimental design.  Values are expressed as 
629 mean ± standard error (n = 6−7). Statistical difference: * p≤0.05 vs RF group by one-way ANOVA. 
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630 Figure 7. OSC-PLS-DA scores plots (PC1 versus PC2) of study samples. Plasma samples from 
631 reference group are indicated in blue, cocoa group in yellow and theobromine group in red. 
632 Figure 8. Tentatively identified metabolites. Plasma concentrations of exogenous (theobromine) 
633 and endogenous (pantothenic acid, glycocholic acid, citrulline, CEDHP and HIAA) metabolites in 
634 the three groups of study (white bars represent reference group (RF), grey bars represent cocoa 
635 group (CC); and striped bars represent theobromine group (TB)) in the 7-day experimental design.  
636 Values are expressed as mean ± standard error (n = 6−7). Statistical difference: * p≤0.05 vs RF 
637 group by one-way ANOVA.
638 Figure 9. Heatmap representation of the association between metabolites (in rows) and some 
639 metabolic and biochemical variables (in columns). Blue color indicates a positive correlation and 
640 red color displays a negative correlation. Color intensity and circle size are proportional to the 
641 correlation coefficients. All displayed correlations were statistically significant (FDR<0.05).
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Table 1. Morphometric measurements. Initial body weight, body weight gain, body length (with and without tail), body mass index, Lee’s index, 
mean food and water intake, food efficiency, rectal temperature and the relative weight of inguinal and retroperitoneal fat, heart, liver, kidney, small 
intestine and colon and caecum in the two study time points and from the three groups of study (reference group (RF);, cocoa group (CC), and 
theobromine group (TB)).  Values are expressed as mean ± standard error (n = 6−7). Statistical difference: * p≤0.05 vs RF group, and  p≤0.05 vs CC 
group by one-way ANOVA. 
 7-days diet group 18-days diet group
Variable RF CC TB RF CC TB
Initial body weight (g) 80.08 ± 2.25 79.98 ± 1.86 80.62 ± 2.17 80.23 ± 2.81 79.82 ± 1.99 79.22 ± 1.14
Body weight gain (g) 35.30 ± 1.61 23.43 ± 0.60* 23.03 ± 0.88* 80.90 ± 2.98 51.53 ± 0.65* 52.11 ± 5.31*
Body length (cm) 28.22 ± 0.32 27.90 ± 0.29 27.70 ± 0.12 29.51 ± 0.28 26.91 ± 0.23* 27.10 ± 0.52*
Body length without tail (cm) 15.03 ± 0.16 15.23 ± 0.16 14.98 ± 0.14 16.50 ± 0.14 14.96 ± 0.17* 14.97 ± 0.23*
Body mass index 0.13 ± 0.00 0.11 ± 0.00* 0.12 ± 0.00* 0.11 ± 0.01 0.10 ± 0.00* 0.10 ± 0.00*
Lee’s index 3.11 ± 0.00 2.93 ± 0.00* 2.99 ± 0.00* 2.81 ± 0.00 2.78 ± 0.00 2.79 ± 0.00
Mean food intake (g/100 g rat/day) 15.34 ± 0.24 16.27 ± 0.24* 15.11 ± 0.14 13.75 ± 0.15 13.77 ± 0.22 13.46 ± 0.20
Mean water intake (g/100 g rat/day) 12.20 ± 0.70 30.10 ± 1.88* 27.93 ± 2.78* 11.28 ± 0.18 20.54 ± 0.41* 17.67 ± 1.17*
Food efficiency 0.34 ± 0.01 0.30 ± 0.01* 0.31 ± 0.01* 0.35 ± 0.01 0.30 ± 0.01* 0.30 ± 0.00*
Rectal temperature (ºC) 35.85 ± 0.13 36.12 ± 0.11 36.03 ± 0.17 36.91 ± 0.34 37.3 ± 0.26 36.49 ± 0.30
Relative weight (%)
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Inguinal fat 0.15 ± 0.02 0.13 ± 0.01 0.11 ± 0.01 0.29 ± 0.03 0.29 ± 0.03 0.19 ± 0.02*
Retroperitoneal fat 0.13 ± 0.02 0.05 ± 0.02* 0.07 ± 0.02* 0.11 ± 0.01 0.04 ± 0.01* 0.03 ± 0.00*
Heart 0.55 ± 0.02 0.57 ± 0.02 0.54 ± 0.02 0.58 ± 0.01 0.65 ± 0.02* 0.59 ± 0.02
Liver 3.82 ± 0.05 3.66 ± 0.09 3.66 ± 0.05 4.12 ± 0.06 3.80 ± 0.05* 3.46 ± 0.17*
Kidney (one) 0.48 ± 0.02 0.57 ± 0.03 0.52 ± 0.01 0.49 ± 0.01 0.51 ± 0.01 0.52 ± 0.03
Small intestine 3.31 ± 0.03 3.67 ± 0.07* 3.62 ± 0.05* 4.19 ± 0.12 4.80 ± 0.20* 4.83 ± 0.14*
Colon and caecum 1.49 ± 0.05 2.42 ± 0.13* 2.66 ± 0.13* 0.98 ± 0.03 1.36 ± 0.03* 1.61 ± 0.06*
Table 2. Biochemical variables measurements. Fold increase of total cholesterol, HDL-c, LDL-c, serum and hepatic TG, and glucose from the three 
groups of study (reference group (RF), cocoa group (CC), theobromine group (TB)) at day 8 and 19.  Values are expressed as mean ± standard error (n 
= 6-7). Statistical difference: * p≤0.05 vs RF group by one-way ANOVA.
 7-days effect 18-days effect
Variable RF CC TB RF CC TB
Total cholesterol 1.00 ± 0.06 0.85  ± 0.03* 0.86  ± 0.02* 1.00 ± 0.01 1.04  ± 0.03 0.98  ± 0.02
HDL-c 1.00 ± 0.08 1.41  ± 0.07* 1.39  ± 0.08* 1.00 ± 0.05 1.34  ± 0.05* 1.24  ± 0.09*
LDL-c 1.00 ± 0.07 0.76  ± 0.04* 0.78  ± 0.03* 1.00 ±0.01 1.00  ± 0.03 0.95  ± 0.03
Plasma TG 1.00 ± 0.08 1.17  ± 0.09 1.13  ± 0.12 1.00 ± 0.11 0.83  ± 0.07 0.54  ± 0.05*
Hepatic TG 1.00 ± 0.02 0.35  ± 0.10* 0.12  ± 0.06* 1.00 ± 0.10 0.35  ± 0.02* 0.34 ± 0.03*
Glucose 1.00 ± 0.06 1.10  ± 0.07 1.02  ± 0.06 1.00 ± 0.23 2.09  ± 0.40* 2.45  ± 0.43*
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